Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

44806 ARTÍCULOS , VIENDO DEL 2086 AL 2100

When Viruses Talk through Extracellular Vesicles: a New Perspective on Sars-Cov-2-Induced Neurodegeneration

Bawne G, Coenen L, Nutma E, Middeldorp J, Lorenowicz MJ.

J Extracell Vesicles. 2026 May;15(5):e70272. doi: 10.1002/jev2.70272.

Pulvinar subdivisions and connectivity patterns across primate species: a comparative perspective

Soares JGM, Correia ARA, Gattass R, Lima B.

Front Neuroanat. 2026 Apr 28;20:1794659. doi: 10.3389/fnana.2026.1794659. eCollection 2026.

Lysophospholipids in Synucleinopathies: A Conceptual Framework Linking Proteostasis and Neuroinflammatory Signaling

Tsukahara T, Haniu H, Matsuda Y.

Brain Sci. 2026 Apr 30;16(5):485. doi: 10.3390/brainsci16050485.

Mitochondrial dysfunction in neurodegenerative disorders: mechanisms and therapeutic advances

Tong Y, He JN, Zhou L, Zhang J, Ho BM, Du L, Yip YWY, Bisnauthsing H, Chan PP, Tham CC, Pang CP, Chu WK.

Mol Biomed. 2026 May 28;7(1):78. doi: 10.1186/s43556-026-00480-x.

Integrating Dopamine and BDNF Hypotheses: The Role of Dopamine-BDNF Crosstalk in Neuropathologies

Alsalloum M, Tsybko A, Naumenko V.

Biochemistry (Mosc). 2026 May;91(5):637-657. doi: 10.1134/S0006297925604125.

Dysphagia Management in Individuals With Parkinson Disease and Cognitive Dysfunction: A Scoping Review

Rangwala R, Lee G, Benge JF, Jones CA.

Arch Phys Med Rehabil. 2026 Mar 22:S0003-9993(26)00620-9. doi: 10.1016/j.apmr.2026.03.012. Online ahead of print.

Wernicke's encephalopathy unmasking progressive supranuclear palsy and Alzheimer's pathology: a diagnostic challenge in an older adult

Defalque I, Ribeiro Da Costa R, Scheffler M, Mendes A.

BMJ Case Rep. 2026 Jan 6;19(1):e269430. doi: 10.1136/bcr-2025-269430.

Pearls & Oy-sters: Reversible Leukoencephalopathy and Parkinsonism Due to CNS Involvement in Cryoglobulinemia

German A, Grotemeyer A, Rothhammer V, Doerfler A, Winkler J, Regensburger M.

Neurology. 2026 Feb 10;106(3):e214622. doi: 10.1212/WNL.0000000000214622. Epub 2026 Jan 8.

In vitro-prepared A30P alpha-synuclein fibrils adopt the conserved and disease-relevant Greek key fold

Milchberg MH, Warmuth OA, Borcik CG, Han R, Harding BD, Dhavale DD, Kotzbauer PT, Wright ER, Schwieters CD, Rienstra CM.

bioRxiv [Preprint]. 2026 Feb 5:2026.02.03.703603. doi: 10.64898/2026.02.03.703603.

Normative modeling of brain function abnormalities in complex pathology requires a whole-brain approach

Kobbersmed JRL, Gohil C, Marquand A, Vidaurre D.

Prog Neurobiol. 2026 May;260:102906. doi: 10.1016/j.pneurobio.2026.102906. Epub 2026 Mar 17.

Plant natural products targeting NLRP3 inflammasome in Parkinson's disease: Molecular activation and regulation to therapeutics

Lu H, Zeng F, Sun J, Li B, Lei Z, Zeng C, Zhu C, Sheng Y, Peng Q, Sun Y, Zhang S.

iScience. 2026 Mar 6;29(4):115257. doi: 10.1016/j.isci.2026.115257. eCollection 2026 Apr 17.

Recent Developments in the Drug Treatment of Parkinson's Disease

Leiter S, Mahlknecht P, Poewe W.

Drugs. 2026 May 21. doi: 10.1007/s40265-026-02327-9. Online ahead of print.

Multifactorial anticholinergic toxicity-like presentation and malignant parkinsonism in Perry syndrome

Takezaki Y, Iriki Y, Madokoro Y, Shimono K, Sato M, Niiyama S, Kamikokuryo C, Kakihana Y.

Parkinsonism Relat Disord. 2026 May;146:108287. doi: 10.1016/j.parkreldis.2026.108287. Epub 2026 Mar 16.

Impact and management of cognition on speech and swallow function in Parkinson's disease

Savage-Black M, Sevitz JS, Rogus-Pulia NM.

J Parkinsons Dis. 2026 May 25:1877718X261444487. doi: 10.1177/1877718X261444487. Online ahead of print.

Aging and the microbiome: implications for health and disease

Gao W, Lee HY, Min KJ.

BMB Rep. 2026 Jan;59(1):40-50. doi: 10.5483/BMBRep.2025-0152.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias